FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Geert D'Haens

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Procedures

Anatomy

Intestinal Mucosa

Co-author Network

Publications

TOP 3
Krisztina B Gecse; Vipul Jairath; Reena Khanna; Mark Löwenberg; Cyriel Y Ponsioen; William J Sandborn; Simon P L Travis; Gijs R van den Brink; Brian G Feagan; Geert D'Haens
Biosimilars in IBD: hope or expectation?
Filip Baert; Philip Caenepeel; olivier dewit; Geert D'Haens; Dennis Franchimont; Elien Glorieus; Edouard Louis; Harald Peeters; Cathérine Reenaers; Gert van Assche
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
Mark Löwenberg; Geert D'Haens
Novel targets for inflammatory bowel disease therapeutics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Geert D'Haens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Krisztina B Gecse; Vipul Jairath; Reena Khanna; Mark Löwenberg; Cyriel Y Ponsioen; William J Sandborn; Simon P L Travis; Gijs R van den Brink; Brian G Feagan; Geert D'Haens
Biosimilars in IBD: hope or expectation?
Gut 2013;62(6):803-7.
2013: Filip Baert; Philip Caenepeel; olivier dewit; Geert D'Haens; Dennis Franchimont; Elien Glorieus; Edouard Louis; Harald Peeters; Cathérine Reenaers; Gert van Assche
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
Journal of Crohn's & colitis 2013;7(2):154-60.
2013: Mark Löwenberg; Geert D'Haens
Novel targets for inflammatory bowel disease therapeutics.
Current gastroenterology reports 2013;15(2):311.
2012: E De Greef; olivier dewit; Geert D'Haens; I Etienne; B Hauser; I Hoffman; Edouard Louis; J Mahachie John; I Paquot; H Peeters; J F Rahier; Michèle Scaillon; F Smets; S Van Biervliet; André Van Gossum; K Van Steen; G Veereman; S Vermeire; P Alliet; W Arts; J C Coche
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease.
Acta gastro-enterologica Belgica 2012;75(4):425-31.
2012: Geert D'Haens; Brian Feagan; Richard N Fedorak; Steven Hanauer; Marc Lémann; Jean-Yves Mary; Walter Reinisch; Paul Rutgeerts; William J Sandborn; Frank Carbonnel; Jean-Frédéric Colombel; Silvio Danese
Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
Gastroenterology 2012;143(6):1461-9.
2012: Geert D'Haens; Marc Ferrante; Patricia Geens; Doreen Iwens; Liesbeth Moortgat; Maja Noman; Isolde Aerden; Filip Baert; Gert van Assche; Gust Van Olmen; Severine Vermeire; Paul Rutgeerts
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
Inflammatory bowel diseases 2012;18(12):2218-24.
2012: Mark Löwenberg; Geert D'Haens
Mucosal healing in Crohn's disease: relevance for clinical outcomes.
Current drug targets 2012;13(10):1248-51.
2012: Paul Rutgeerts; William J Sandborn; Gert van Assche; Douglas C Wolf; Karel Geboes; Ashish Kumar; Andreas Lazar; Kathleen G Lomax; Paul F Pollack; Walter Reinisch; Anne Camez; Jean-Frédéric Colombel; Geert D'Haens
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.
Gastroenterology 2012;142(5):1102-1111.e2.
2012: Harry Bleiberg; I Deleu; Geert D'Haens; A Efira; M Paesmans; M Peeters; H Rezaei Kalantari; A Vandebroek; P Vergauwe; Y Humblet
A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.
Acta gastro-enterologica Belgica 2012;75(1):14-21.
2010: William J Sandborn; Maria Abreu; Geert D'Haens; Jean-Frédéric Colombel; Severine Vermeire; Krassimir Mitchev; Corinne Jamoul; Richard N Fedorak; Martina E Spehlmann; Douglas C Wolf; Scott Lee; Paul Rutgeerts
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(8):688-695.e2.
2010: Martin H Holtmann; Frank Krummenauer; Christina Claas; Kristina Kremeyer; Dirk Lorenz; Olivia Rainer; Iris Vogel; Ulrich Böcker; Stephan Böhm; Carsten Büning; Rainer Duchmann; Guido Gerken; Hans Herfarth; Norbert Lügering; Wolfgang Kruis; Max Reinshagen; Jan Schmidt; Andreas Stallmach; Jürgen Stein; Andreas Sturm; Peter R Galle; Daan W Hommes; Geert D'Haens; Paul Rutgeerts; Markus F Neurath
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
Digestive diseases and sciences 2010;55(4):1066-78.
2010: Filip Baert; Liesbeth Moortgat; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Martine De Vos; Pieter Stokkers; Daniel Hommes; Paul Rutgeerts; Severine Vermeire; Geert D'Haens
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Gastroenterology 2010;138(2):463-8; quiz e10-1.
2010: Marc Ferrante; Geert D'Haens; olivier dewit; Filip Baert; Jan Holvoet; Karel Geboes; Gert De Hertogh; Gert van Assche; Severine Vermeire; Paul Rutgeerts
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.
Inflammatory bowel diseases 2010;16(2):243-9.
2010: J F Rahier; Tom G Moreels; P De Munter; Geert D'Haens
Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium.
Acta gastro-enterologica Belgica 2010;73(1):41-5.
2009: Marc Ferrante; Geert D'Haens; Paul Rutgeerts; Séverine Vermeire; Gert van Assche
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Current gastroenterology reports 2009;11(6):504-8.
2009: Darrell S Pardi; Geert D'Haens; Bo Shen; Simon Campbell; Paolo Gionchetti
Clinical guidelines for the management of pouchitis.
Inflammatory bowel diseases 2009;15(9):1424-31.
2009: Laurent Peyrin-Biroulet; Pierre Deltenre; Sandro Ardizzone; Geert D'Haens; Stephen B Hanauer; Hans Herfarth; Marc Lémann; Jean-Frédéric Colombel
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
The American journal of gastroenterology 2009;104(8):2089-96.
2009: Jean-Frédéric Colombel; D A Schwartz; William J Sandborn; M A Kamm; Geert D'Haens; Paul Rutgeerts; Robert Enns; Remo Panaccione; Stefan Schreiber; J Li; J D Kent; K G Lomax; Paul F Pollack
Adalimumab for the treatment of fistulas in patients with Crohn's disease.
Gut 2009;58(7):940-8.
2009: Eric Van Cutsem; Claus-Henning Köhne; Erika Hitre; Jerzy Zaluski; Chung-Rong Chang Chien; Anatoly Makhson; Geert D'Haens; Tamás Pintér; Robert Lim; György Bodoky; Jae Kyung Roh; Gunnar Folprecht; Paul Ruff; Christopher Stroh; Sabine Tejpar; Michael Schlichting; Johannes Nippgen; Philippe Rougier
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
The New England journal of medicine 2009;360(14):1408-17.
2008: Brian G Feagan; Remo Panaccione; William J Sandborn; Geert D'Haens; Stefan Schreiber; Paul J Rutgeerts; Edward V Loftus; Kathleen G Lomax; Andrew P Yu; Eric Q Wu; Jingdong Chao; Parvez Mulani
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.
Gastroenterology 2008;135(5):1493-9.
2008: Stijn Van Gool; Lieve Van Casteren; Otto Buchel; Eric Frans; Francisca Dedeurwaerdere; August Van Olmen; Geert D'Haens; Veerle Moons; Paul Christiaens
Cytomegalovirus colitis in an apparently immunecompetent host after biliopancreatic diversion for obesity.
Acta gastro-enterologica Belgica 2008;71(4):423-6.
2008: Geert D'Haens; Severine Vermeire; Gert van Assche; Maja Noman; Isolde Aerden; Gust Van Olmen; Paul Rutgeerts
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
Gastroenterology 2008;135(4):1123-9.
2008: Gert van Assche; Charlotte Magdelaine-Beuzelin; Geert D'Haens; Filip Baert; Maja Noman; Severine Vermeire; David Ternant; Hervé Watier; Gilles Paintaud; Paul Rutgeerts
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Gastroenterology 2008;134(7):1861-8.
2008: Stefanie Kulnigg; Simeon Stoinov; Vladimir Simanenkov; Larisa V Dudar; Waldemar Karnafel; Luis Chaires Garcia; Alicia M Sambuelli; Geert D'Haens; Christoph Gasche
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
The American journal of gastroenterology 2008;103(5):1182-92.
2008: Brian G Feagan; William J Sandborn; Ulrich Mittmann; Simon Bar-Meir; Geert D'Haens; Marc Bradette; Albert Cohen; Chrystian Dallaire; Terry P Ponich; J W D McDonald; Xavier Hébuterne; Pierre Paré; Pavel Klvana; Yaron Niv; Sandro Ardizzone; Olga Alexeeva; Alaa Rostom; Gediminas Kiudelis; Johannes Spleiss; Denise Gilgen; Margaret K Vandervoort; Cindy J Wong; Guang Yong Zou; Allan Donner; Paul Rutgeerts
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
JAMA : the journal of the American Medical Association 2008;299(14):1690-7.
2008: Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van de Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Lancet 2008;371(9613):660-7.
2008: Paul Christiaens; Sofie Decock; Otto Buchel; Katrien Bulté; Veerle Moons; Geert D'Haens; Gust Van Olmen
Endoscopic trimming of metallic stents with the use of argon plasma.
Gastrointestinal endoscopy 2008;67(2):369-71.
2007: Severine Vermeire; Maja Noman; Gert van Assche; Filip Baert; Geert D'Haens; Paul Rutgeerts
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.
Gut 2007;56(9):1226-31.
2007: William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Jean-Frédéric Colombel; Remo Panaccione; Geert D'Haens; Ju Li; Marie R Rosenfeld; Jeffrey D Kent; Paul F Pollack
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Annals of internal medicine 2007;146(12):829-38.
2007: Geert D'Haens
Risks and benefits of biologic therapy for inflammatory bowel diseases.
Gut 2007;56(5):725-32.
2007: Geert D'Haens; William J Sandborn; Brian G Feagan; Karel Geboes; Stephen B Hanauer; E Jan Irvine; Marc Lémann; Philippe Marteau; Paul Rutgeerts; Jurgen Schölmerich; Lloyd R Sutherland
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Gastroenterology 2007;132(2):763-86.
2007: Edouard Louis; Jacques Boverie; olivier dewit; Filip Baert; Martine De Vos; Geert D'Haens
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study.
Acta gastro-enterologica Belgica 2007;70(1):15-9.
2006: Geert D'Haens; Marco Daperno
Advances in biologic therapy for ulcerative colitis and Crohn's disease.
Current gastroenterology reports 2006;8(6):506-12.
2006: Geert D'Haens; D Hommes; L Engels; Filip Baert; L van der Waaij; P Connor; J Ramage; olivier dewit; M Palmen; D Stephenson; R Joseph
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
Alimentary pharmacology & therapeutics 2006;24(7):1087-97.
2006: Martin H Holtmann; Frank Krummenauer; Christina Claas; Kristina Kremeyer; Dirk Lorenz; Olivia Rainer; Iris Vogel; Ulrich Böcker; Stephan Böhm; Carsten Büning; Rainer Duchmann; Guido Gerken; Hans Herfarth; Norbert Lügering; Wolfgang Kruis; Max Reinshagen; Jan Schmidt; Andreas Stallmach; Jürgen Stein; Andreas Sturm; Peter R Galle; Daan W Hommes; Geert D'Haens; Paul Rutgeerts; Markus F Neurath
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.
Digestive diseases and sciences 2006;51(9):1516-24.
2006: Marc Ferrante; Gert De Hertogh; Tibor Hlavaty; Geert D'Haens; Freddy Penninckx; Andre D'Hoore; Severine Vermeire; Paul Rutgeerts; Karel Geboes; Gert van Assche
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence.
Gastroenterology 2006;130(6):1595-606.
2006: Stefan Schreiber; Brian G Feagan; Geert D'Haens; Jean-Frédéric Colombel; Karel Geboes; Mikhail Yurcov; Vasily Isakov; Oleg Golovenko; Charles N Bernstein; Diether Ludwig; Trevor Winter; Ulrich Meier; Chan Yong; Jürgen Steffgen
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(3):325-34.
2006: S P L Travis; E F Stange; Marc Lémann; T Oresland; Y Chowers; Alastair Forbes; Geert D'Haens; G Kitis; Antoine Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J McC Mortensen
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
Gut 2006;55 Suppl 1():i16-35.
2006: Geert D'Haens
Dysplasia and cancer in ulcerative colitis: too many questions, too few answers.
Digestion 2006;73(1):9-10.
2005: Geert D'Haens
Infliximab for ulcerative colitis: finally some answers.
Gastroenterology 2005;128(7):2161-4.
2005: Paul Rutgeerts; Gert van Assche; Severine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.
Gastroenterology 2005;128(4):856-61.
2004: Geert D'Haens; Tibor Hlavaty
Advances in medical therapy for Crohn's disease.
Current gastroenterology reports 2004;6(6):496-505.
2004: Marco Daperno; Geert D'Haens; Gert van Assche; Filip Baert; Philippe Bulois; Vincent Maunoury; Raffaello Sostegni; Rodolfo Rocca; Angelo Pera; Annemie Gevers; Jean-Yves Mary; Jean-Frédéric Colombel; Paul Rutgeerts
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Gastrointestinal endoscopy 2004;60(4):505-12.
2004: Filip Baert; Severine Vermeire; Maja Noman; Gert van Assche; Geert D'Haens; Paul Rutgeerts
Management of ulcerative colitis and Crohn's disease.
Acta clinica Belgica 2004;59(5):304-14.
2004: Geert D'Haens
Mucosal healing in pediatric Crohn's disease: the goal of medical treatment.
Inflammatory bowel diseases 2004;10(4):479-80.
2004: L Marchal; Geert D'Haens; Gert van Assche; Severine Vermeire; Maja Noman; Marc Ferrante; Martin Hiele; M Bueno De Mesquita; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
Alimentary pharmacology & therapeutics 2004;19(7):749-54.
2004: Joris Arts; Geert D'Haens; Miranda Zeegers; Gert van Assche; Martin Hiele; Andre D'Hoore; Freddy Penninckx; Severine Vermeire; Paul Rutgeerts
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.
Inflammatory bowel diseases 2004;10(2):73-8.
2004: Monique M Elseviers; Geert D'Haens; E Lerebours; C Plane; J C Stolear; G Riegler; G Capasso; Marc Van Outryve; P Mishevska-Mukaetova; S Djuranovic; Paul A Pelckmans; Marc E De Broe
Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?
Clinical nephrology 2004;61(2):83-9.
2003: Herbert Tilg; Harald Vogelsang; Othmar Ludwiczek; Herbert Lochs; Arthur Kaser; J-F Colombel; H Ulmer; Paul Rutgeerts; S Krüger; A Cortot; Geert D'Haens; Marieluise Harrer; Christoph Gasche; Fritz Wrba; I Kuhn; Walter Reinisch
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.
Gut 2003;52(12):1728-33.
2003: Gert van Assche; Geert D'Haens; Maja Noman; Severine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.
Gastroenterology 2003;125(4):1025-31.
2003: Geert D'Haens
Infliximab as disease-modifying therapy.
European journal of gastroenterology & hepatology 2003;15(3):233-7.
2003: Geert D'Haens
Anti-TNF therapy for Crohn's disease.
Current pharmaceutical design 2003;9(4):289-94.
2002: Geert D'Haens; Marco Daperno
Advances in medical therapy for Crohn's disease.
Current gastroenterology reports 2002;4(6):506-12.
2002: Gert van Assche; Filip Baert; Marc De Reuck; Martine De Vos; Olivier De Wit; Pierre Hoang; Edouard Louis; Fazia Mana; Paul A Pelckmans; Paul Rutgeerts; André Van Gossum; Geert D'Haens
The role of aminosalicylates in the treatment of ulcerative colitis.
Acta gastro-enterologica Belgica 2002;65(4):196-9.
2002: Severine Vermeire; Edouard Louis; An Carbonez; Gert van Assche; Maja Noman; Jacques Belaiche; Martine De Vos; André Van Gossum; Paul Pescatore; René Fiasse; Paul A Pelckmans; Hendrik Reynaert; Geert D'Haens; Paul Rutgeerts
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease.
The American journal of gastroenterology 2002;97(9):2357-63.
2002: Edouard Louis; Severine Vermeire; Paul Rutgeerts; Martine De Vos; André Van Gossum; Paul Pescatore; René Fiasse; Paul A Pelckmans; Hendrik Reynaert; Geert D'Haens; Michel Malaise; Jacques Belaiche
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism.
Scandinavian journal of gastroenterology 2002;37(7):818-24.
2002: Filip Baert; Alain Schmit; Geert D'Haens; Franceska Dedeurwaerdere; Edouard Louis; Marc Cabooter; Martine De Vos; Fernand Fontaine; Serge Naegels; Piet Schurmans; Hedwig Stals; Karel Geboes; Paul Rutgeerts
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up.
Gastroenterology 2002;122(1):20-5.
2001: Geert D'Haens; C Swijsen; Maja Noman; Liesbeth Lemmens; Jan L Ceuppens; H Agbahiwe; Karel Geboes; Paul Rutgeerts
Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.
The American journal of gastroenterology 2001;96(9):2564-8.
2001: Geert D'Haens; Liesbeth Lemmens; Karel Geboes; L Vandeputte; Frank Van Acker; Luc Mortelmans; M Peeters; Severine Vermeire; Freddy Penninckx; Frederik Nevens; Martin Hiele; Paul Rutgeerts
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.
Gastroenterology 2001;120(6):1323-9.
2001: Geert D'Haens
Tissue effects of anti-TNF therapies.
Acta gastro-enterologica Belgica 2001;64(2):173-6.
2001: Freddy Cornillie; D Shealy; Geert D'Haens; Karel Geboes; Gert van Assche; J Ceuppens; C Wagner; TF Schaible; Scott Plevy; Stephan R Targan; Paul Rutgeerts
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.
Alimentary pharmacology & therapeutics 2001;15(4):463-73.
2000: Geert D'Haens
Medical management of major internal fistulae in Crohn's disease.
Inflammatory bowel diseases 2000;6(3):244-5.
2000: M Melange; Geert D'Haens; Martine DeVos; A Kartheuser; Edouard Louis; P Pattyn; P Pelckmans; F Penninckx; P Potvin; M Schapira; J Van de Stadt; André Van Gossum
The medical management of severe acute and chronic ulcerative colitis--current recommendations from the Belgian Working Group.
Acta gastro-enterologica Belgica 2000;63(3):273-4.
2000: M Craninx; Geert D'Haens; Kristof Cokelaere; Filip Baert; Freddy Penninckx; Andre D'Hoore; Nadine Ectors; Paul Rutgeerts; Karel Geboes
Crohn's disease and intestinal endometriosis: an intriguing co-existence.
European journal of gastroenterology & hepatology 2000;12(2):217-21.
2000: Christoph Gasche; J Scholmerich; J Brynskov; Geert D'Haens; S B Hanauer; E Jan Irvine; D P Jewell; D Rachmilewitz; David B Sachar; W J Sandborn; L R Sutherland
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
Inflammatory bowel diseases 2000;6(1):8-15.
1999: Geert D'Haens
Prevention of postoperative recurrence in Crohn's disease.
Current gastroenterology reports 1999;1(6):476-81.
1999: Geert D'Haens; Paul Rutgeerts
Postoperative recurrence of Crohn's disease: pathophysiology and prevention.
Inflammatory bowel diseases 1999;5(4):295-303.
1999: Geert D'Haens; Karel Geboes; Paul Rutgeerts
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine.
Gastrointestinal endoscopy 1999;50(5):667-71.
1999: Paul Rutgeerts; Geert D'Haens; Stephan R Targan; Eric A Vasiliauskas; S B Hanauer; Daniel H Present; L Mayer; R A Van Hogezand; T Braakman; KL DeWoody; TF Schaible; Sander J H van Deventer
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Gastroenterology 1999;117(4):761-9.
1999: Filip Baert; K Wouters; Geert D'Haens; P Hoang; Serge Naegels; Francois D'heygere; J Holvoet; Edouard Louis; Martine DeVos; Karel Geboes
Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis.
Gut 1999;45(3):375-81.
1999: Geert D'Haens
Infliximab (Remicade), a new biological treatment for Crohn's disease.
Italian journal of gastroenterology and hepatology 1999;31(6):519-20.
1999: Jacques Belaiche; Edouard Louis; Geert D'Haens; M Cabooter; Serge Naegels; Martine De Vos; Fernand Fontaine; P Schurmans; Filip Baert; M De Reuck; René Fiasse; J Holvoet; Alain Schmit; Marc Van Outryve
Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group.
The American journal of gastroenterology 1999;94(8):2177-81.
1999: Geert D'Haens; Sander J H van Deventer; R Van Hogezand; D Chalmers; C Kothe; Filip Baert; T Braakman; TF Schaible; Karel Geboes; Paul Rutgeerts
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
Gastroenterology 1999;116(5):1029-34.
1999: L Vandeputte; Geert D'Haens; Filip Baert; Paul Rutgeerts
Methotrexate in refractory Crohn's disease.
Inflammatory bowel diseases 1999;5(1):11-5.
1999: Filip Baert; Geert D'Haens; M Peeters; Martin Hiele; TF Schaible; D Shealy; Karel Geboes; Paul Rutgeerts
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Gastroenterology 1999;116(1):22-8.
1998: Geert D'Haens; A Verstraete; K Cheyns; Isolde Aerden; R Bouillon; Paul Rutgeerts
Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease.
Alimentary pharmacology & therapeutics 1998;12(5):419-24.
1998: Geert D'Haens; Peter Suenaert; R Westhovens; Paul Rutgeerts
Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.
Inflammatory bowel diseases 1998;4(1):27-8.
1998: Geert D'Haens; Karel Geboes; M Peeters; Filip Baert; Freddy Penninckx; Paul Rutgeerts
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.
Gastroenterology 1998;114(2):262-7.
1997: Geert D'Haens; Karel Geboes; M Peeters; Filip Baert; Nadine Ectors; Paul Rutgeerts
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.
The American journal of gastroenterology 1997;92(8):1275-9.
1997: André Van Gossum; Alain Schmit; M Adler; C Chioccioli; René Fiasse; P Louwagie; Geert D'Haens; Paul Rutgeerts; Martine De Vos; Hendrik Reynaert; G Devis; Jacques Belaiche; Marc Van Outryve
Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group.
Acta gastro-enterologica Belgica 1997;60(3):197-200.
1997: Geert D'Haens; Karel Geboes; E Ponette; Freddy Penninckx; Paul Rutgeerts
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease.
Gastroenterology 1997;112(5):1475-81.
1995: Geert D'Haens; A E Gasparaitis; Stephen B Hanauer
Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease.
Gut 1995;36(5):715-7.
1995: W E Peetermans; Geert D'Haens; Jan L Ceuppens; Paul Rutgeerts; Karel Geboes
Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease.
Gastroenterology 1995;108(1):75-82.
1994: Geert D'Haens; Martin Hiele; Paul Rutgeerts; K Geboes; J L Ceuppens
Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.
Gut 1994;35(12):1728-33.
1994: Geert D'Haens; Paul Rutgeerts
Postoperative recurrence of Crohn's disease: pathogenesis and prevention.
Acta gastro-enterologica Belgica 1994;57(5-6):311-3.
1994: Paul Rutgeerts; Geert D'Haens; Martin Hiele; Karel Geboes; G Vantrappen
Appendectomy protects against ulcerative colitis.
Gastroenterology 1994;106(5):1251-3.
1994: Geert D'Haens; Paul Rutgeerts; Karel Geboes; G Vantrappen
The natural history of esophageal Crohn's disease: three patterns of evolution.
Gastrointestinal endoscopy 1994;40(3):296-300.
1993: Geert D'Haens; Y Breysem; Paul Rutgeerts; B van Besien; Karel Geboes; E Ponette; G Vantrappen
Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositories.
Journal of clinical gastroenterology 1993;17(3):207-12.
1993: Geert D'Haens; B A Lashner; Stephen B Hanauer
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
The American journal of gastroenterology 1993;88(8):1174-8.
1993: Geert D'Haens; M A Ruchim; M J Goldberg; A L Baker
Massive intra-hepatic and extra-hepatic bile cast formation after cholecystectomy.
Gastrointestinal endoscopy 1993;39(4):579-81.